Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension.
Hojná S, Rauchová H, Malínská H, Marková I, Hüttl M, Papoušek F, Behuliak M, Miklánková D, Vaňourková Z, Neckář J, Kadlecová M, Kujal P, Zicha J, Vaněčková I.
Hojná S, et al. Among authors: miklankova d.
Biomed Pharmacother. 2021 Dec;144:112246. doi: 10.1016/j.biopha.2021.112246. Epub 2021 Oct 1.
Biomed Pharmacother. 2021.
PMID: 34601191
Free article.